Evidence map›Paper›PMID 35269266›Full record

ReviewNanomaterials (Basel, Switzerland)2022

Engineered Nanotechnology: An Effective Therapeutic Platform for the Chronic Cutaneous Wound.

Suhasini Mallick, Moupriya Nag, Dibyajit Lahiri, Soumya Pandit, Tanmay Sarkar, Siddhartha Pati, Nilesh Prakash Nirmal, Hisham Atan Edinur, Zulhisyam Abdul Kari, Muhammad Rajaei Ahmad Mohd Zain and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 3 countries.

Suhasini MallickDepartment of Biotechnology, Maulana Abul Kalam Azad University of Technology, Nadia 741249, India.
Moupriya NagDepartment of Biotechnology, University of Engineering & Management, Kolkata 700156, India.
Dibyajit LahiriDepartment of Biotechnology, University of Engineering & Management, Kolkata 700156, India.
Soumya PanditDepartment of Life Sciences, Sharda University, Noida 201310, India.ORCID 0000-0001-8045-4675
Tanmay SarkarDepartment of Food Processing Technology, Malda Polytechnic, West Bengal State Council of Technical Education, Government of West Bengal, Malda 732102, India.ORCID 0000-0003-3869-1604
Siddhartha PatiNatNov Bioscience Private Limited, Balasore 756001, India.ORCID 0000-0002-8276-0008
Nilesh Prakash NirmalInstitute of Nutrition, Mahidol University, 999 Phutthamonthon 4 Road, Salaya, Nakhon Pathom 73170, Thailand.ORCID 0000-0003-2732-4534
Hisham Atan EdinurSchool of Health Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian 16150, Malaysia.ORCID 0000-0002-3379-6063
Zulhisyam Abdul KariDepartment of Agricultural Science, Faculty of Agro-Based Industry, Universiti Malaysia Kelantan, Jeli 17600, Malaysia.ORCID 0000-0002-3160-7839
Muhammad Rajaei Ahmad Mohd ZainDepartment of Orthopaedics, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian 16150, Malaysia.ORCID 0000-0002-1784-5558
Rina Rani RayDepartment of Biotechnology, Maulana Abul Kalam Azad University of Technology, Nadia 741249, India.
Maulana Abul Kalam Azad University of Technology, West Bengal · INUniversiti Sains Malaysia · MYUniversity of Engineering & Management · INGovernment of West Bengal · INMahidol University · THSharda University · INUniversiti Malaysia Kelantan · MY

Funding

All India Council for Technical Education AICTE doctoral fellowship
6 · The paper itself

Abstract

The healing of chronic wound infections, especially cutaneous wounds, involves a complex cascade of events demanding mutual interaction between immunity and other natural host processes. Wound infections are caused by the consortia of microbial species that keep on proliferating and produce various types of virulence factors that cause the development of chronic infections. The mono- or polymicrobial nature of surface wound infections is best characterized by its ability to form biofilm that renders antimicrobial resistance to commonly administered drugs due to poor biofilm matrix permeability. With an increasing incidence of chronic wound biofilm infections, there is an urgent need for non-conventional antimicrobial approaches, such as developing nanomaterials that have intrinsic antimicrobial-antibiofilm properties modulating the biochemical or biophysical parameters in the wound microenvironment in order to cause disruption and removal of biofilms, such as designing nanomaterials as efficient drug-delivery vehicles carrying antibiotics, bioactive compounds, growth factor antioxidants or stem cells reaching the infection sites and having a distinct mechanism of action in comparison to antibiotics-functionalized nanoparticles (NPs) for better incursion through the biofilm matrix. NPs are thought to act by modulating the microbial colonization and biofilm formation in wounds due to their differential particle size, shape, surface charge and composition through alterations in bacterial cell membrane composition, as well as their conductivity, loss of respiratory activity, generation of reactive oxygen species (ROS), nitrosation of cysteines of proteins, lipid peroxidation, DNA unwinding and modulation of metabolic pathways. For the treatment of chronic wounds, extensive research is ongoing to explore a variety of nanoplatforms, including metallic and nonmetallic NPs, nanofibers and self-accumulating nanocarriers. As the use of the magnetic nanoparticle (MNP)-entrenched pre-designed hydrogel sheet (MPS) is found to enhance wound healing, the bio-nanocomposites consisting of bacterial cellulose and magnetic nanoparticles (magnetite) are now successfully used for the healing of chronic wounds. With the objective of precise targeting, some kinds of "intelligent" nanoparticles are constructed to react according to the required environment, which are later incorporated in the dressings, so that the wound can be treated with nano-impregnated dressing material in situ. For the effective healing of skin wounds, high-expressing, transiently modified stem cells, controlled by nano 3D architectures, have been developed to encourage angiogenesis and tissue regeneration. In order to overcome the challenge of time and dose constraints during drug administration, the approach of combinatorial nano therapy is adopted, whereby AI will help to exploit the full potential of nanomedicine to treat chronic wounds.

Indexed as

artificial intelligencebiofilmchronic woundnanocompositenanoparticle

Identifiers

PMID35269266
PMCPMC8911807
OpenAlexW4214514267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.